Skip to main content

FDA To Decide The Fate Of JUUL Vaping Products

FDA To Decide The Fate Of JUUL Vaping Products

FDA To Decide The Fate Of JUUL Vaping Products

Introduction

Federal regulators are looking to discontinue the sale of JUUL vaping pods from the market, considering the nicotine addiction among the teens and illicit product marketing.

JUUL tried to convince the U.S. Food and Drug Administration (FDA) by submitting a 125,000-page application that highlighted the benefits of e-cigarettes stating that vaping pods help smokers quit smoking. The company even mentioned in the application that those benefits surpass the teen vaping epidemic caused because of the JUUL pods.

JUUL’s extensive marketing of vaping pods is linked to an increase in nicotine addiction among teens across the country. The high levels of nicotine in JUUL pods often result in long-term health problems among the users.

Manufacturers of tobacco products such as e-cigarettes, pipe tobacco, cigars, and hookah tobacco that were on the market as of August 8, 2016, are required to submit applications to the FDA before May 12, 2020, as ordered by a U.S. District Court in Maryland in July 2019. Later, the deadline was revised to September 9, 2021, considering the ongoing COVID-19 pandemic. The application will include the marketing strategies that the manufacturers will implement to prevent underage use of vaping pods.

The final deadline for the FDA to decide the fate of the JUUL pods is September 9. Currently, the company faces more than 4500 vaping lawsuits from school districts, municipalities, and individuals. All the lawsuits allege the company of fueling nicotine addiction among teens, young adults, and prior non-smokers by implementing deceptive marketing strategies through social media and other marketing platforms.

Earlier, the FDA forced JUUL to discontinue most of the vaping pod flavors from the market that resulted in huge losses to the company. The company shut down operations in 14 countries as the sales dropped by about $500 million. The company earlier had a market value of $40 billion, which is now reduced to $5 billion. Experts believe that if the FDA rejects JUUL's application, it will eventually lead to the end of JUUL Labs as a company.

It is reported that JUUL has bought the May/June issue of the American Journal of Health Behavior for $51,000 to get 11 studies published which will highlight the benefits of vaping products. The company has even paid an additional amount of $6,500, so the users can get free access to the studies.

JUUL pods were first introduced in 2015, and within a short period, the products gained popularity among teens and young adults across the United States.

Earlier, a federal jury announced a landmark settlement that orders electronic cigarette giant Juul Labs Inc. to pay $40 million to North Carolina in litigation that accuses the company of fueling teen vaping.

It is first of its kind agreement with a state. North Carolina Attorney General Josh Stein sued the company by placing allegations that Juul’s unfair and deceptive marketing strategies encouraged the use of vaping products among the youth.

The agreement states that the vaping manufacturer Juul will no longer advertise its products to anyone under 21 in North Carolina. It also states that the company should limit the sales of its products by selling only behind counters at retailers who have ID scanners that will detect the customer's age.

A spokesperson for Juul said that the company is already experiencing a decline in the sale of its products post the discontinuation of advertising and social media promotion. The company is effectively looking forward to combating underage vaping by taking necessary measures.

Juul faces individual lawsuits from several states, and since February 2020, a group of 39 state attorneys general is cooperatively investigating the company’s marketing and products. The company even faces hundreds of personal injury lawsuits, which include claims from customers and families of young people affected because of vaping. All these lawsuits are consolidated before Judge William H. Orrick in a California federal court.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!